Diastolic Blood Pressure Management with Hydralazine

Introduction to Hydralazine

The American Heart Association recommends a diastolic blood pressure (DBP) parameter of 60 mmHg for holding hydralazine, particularly in patients with diabetes mellitus, those over 60 years of age, or those with coronary artery disease and heart failure with evidence of myocardial ischemia 1

Hydralazine is a direct vasodilator that can cause significant and unpredictable blood pressure reductions with a prolonged duration of action (2-4 hours) 2
Hydralazine is associated with sodium and water retention and reflex tachycardia, making it less desirable as a first-line agent for acute hypertension treatment 3

For most hypertensive patients, the target DBP is <80 mmHg, according to the European Society of Cardiology 4
When systolic BP is at or below target (120-129 mmHg) but diastolic BP is not at target (≥80 mmHg), intensifying treatment to achieve a diastolic BP of 70-79 mmHg may be considered, as recommended by the European Society of Cardiology 4
In patients with elevated DBP who have coronary artery disease and heart failure with evidence of myocardial ischemia, caution is advised in inducing falls of DBP below 60 mmHg if the patient has diabetes mellitus or is over 60 years of age, as recommended by the American Heart Association 1

Blood pressure typically begins to decrease within 10-30 minutes after hydralazine administration, and the effect lasts 2-4 hours 2
If hydralazine has already been administered, wait 2-4 hours to assess full effect before giving additional doses 2
Monitor for potential adverse effects including reflex tachycardia 2 and sodium and water retention 2

For hypertensive emergencies, the immediate goal is to decrease mean BP by 15-25% with the target to achieve SBP 140-150 mmHg and DBP 90-100 mmHg, as recommended by the European Society of Cardiology 5
For severe pre-eclampsia, IV hydralazine is widely used, particularly in North America, despite being associated with adverse effects related to maternal hypotension, according to the European Society of Cardiology 5

Antihypertensive drugs should be reduced or ceased if diastolic BP falls below 80 mmHg in pregnancy-related hypertension, and this principle extends to general hypertension management, as recommended by the American College of Cardiology 6

Hydralazine causes reflex tachycardia and sodium/water retention, which can be particularly problematic in patients with underlying cardiac conditions, according to the European Society of Cardiology 7
The drug is associated with drug-induced lupus-like syndrome at higher doses, as reported by the European Society of Cardiology 7

The systolic BP of 124 mmHg is already at or below target for most patients, with a target <130 mmHg for high-risk patients, as recommended by the American Heart Association 7
Hold all antihypertensive medications until diastolic BP recovers to at least 60-70 mmHg, as suggested by the American College of Cardiology 6
Assess for symptoms of hypoperfusion, such as dizziness, syncope, chest pain, altered mental status, or oliguria, as recommended by the American Heart Association 6
Evaluate for causes of the low diastolic pressure, including overmedication, volume depletion, sepsis, or cardiac dysfunction, according to the European Society of Cardiology 8

For hypertensive emergencies, consider more predictable IV agents with shorter half-lives, such as nicardipine, labetalol, or clevidipine, instead of hydralazine, as recommended by the European Society of Cardiology 9
Hydralazine is no longer recommended as first-line therapy for acute hypertension due to its unpredictability and association with adverse perinatal outcomes and hypotension, according to the European Society of Cardiology 8, 9